Mingjiang Xu Selected Research

Mingjiang Xu Research Topics

Disease

15	Neoplasms (Cancer) 10/2021 - 02/2007
11	Leukemia 01/2022 - 07/2013
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 04/2015
8	Primary Myelofibrosis (Myelosclerosis) 12/2010 - 06/2005
6	Inflammation (Inflammations) 09/2021 - 04/2013
6	Polycythemia Vera 11/2010 - 02/2007
4	Fibrosis (Cirrhosis) 01/2021 - 09/2014
3	Hepatitis 09/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2021 - 10/2018
3	Fatty Liver 01/2020 - 05/2014
3	Insulin Resistance 01/2015 - 11/2012
2	Body Weight (Weight, Body) 09/2021 - 01/2021
2	Dyslipidemias (Dyslipidemia) 09/2021 - 11/2012
2	Infections 01/2021 - 10/2018
2	Hyperglycemia 01/2021 - 11/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 06/2015
2	Obesity 01/2015 - 11/2012
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 12/2014 - 02/2007
2	Alcoholic Hepatitis 11/2014 - 09/2014
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 09/2014 - 05/2014
2	Pseudarthrosis (Pseudoarthrosis) 12/2013 - 12/2013
2	Osteoporosis 12/2013 - 01/2012
2	Splenomegaly 10/2011 - 05/2008
2	Hyperplasia 05/2008 - 08/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021
1	Non-alcoholic Fatty Liver Disease 09/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 03/2020
1	Immune System Diseases (Immune Disorders) 03/2020
1	Alcoholic Fatty Liver 01/2020
1	Binge Drinking 01/2019
1	End Stage Liver Disease 10/2018
1	Hypersensitivity (Allergy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2017
1	Heart Failure 10/2015

Drug/Important Bio-Agent (IBA)

7	ChromatinIBA 01/2022 - 07/2007
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2013
6	Pharmaceutical PreparationsIBA 09/2021 - 02/2007
5	CytokinesIBA 01/2021 - 04/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2012
3	Concanavalin AIBA 01/2021 - 01/2015
3	Interleukin-22 (IL-22)IBA 01/2021 - 09/2014
3	Transcription Factors (Transcription Factor)IBA 03/2020 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2020 - 12/2013
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 05/2014
3	EnzymesIBA 11/2018 - 09/2009
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2008
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 09/2017
2	ChemokinesIBA 10/2019 - 11/2014
2	5-hydroxymethylcytosineIBA 09/2017 - 07/2013
2	TOR Serine-Threonine KinasesIBA 04/2016 - 12/2014
2	Biological ProductsIBA 10/2011 - 08/2007
2	AntioxidantsIBA 09/2009 - 01/2008
2	Thrombopoietin (c-mpl Ligand)IBA 05/2008 - 08/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 08/2007
1	AcetyltransferasesIBA 10/2021
1	bicyclolIBA 09/2021
1	NucleophosminIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Cyclin-Dependent Kinase 9IBA 01/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Core Binding Factor Alpha 2 SubunitIBA 03/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	SirtuinsIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	AcetaldehydeIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	CorticosteroneIBA 01/2019
1	coactivator-associated arginine methyltransferase 1IBA 11/2018
1	MethyltransferasesIBA 11/2018
1	Arginine (L-Arginine)FDA Link 11/2018
1	Lipocalin-2IBA 10/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	alpha-hydroxyglutarateIBA 01/2018
1	A-Form DNA (A-DNA)IBA 09/2017
1	DioxygenasesIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2016
1	Therapeutic UsesIBA 04/2016

Therapy/Procedure

9	Therapeutics 01/2021 - 06/2010
1	Intraperitoneal Injections 10/2018
1	Radiotherapy 01/2018